Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Why the Collapse of Firearm Violence Prevention Is a Threat to U.S. Lives.
- NJACTS Community Engagement Core COVID-19 Resources
- NJIT Researcher Fortifies Virtual Reality Tech for Cancer Patient Emergencies.
- Join Us Today for Rutgers Health Policy and Advocacy Corps
- Rutgers-Newark Launches Institute on Improving Communities Through AI and Interdisciplinary Data Work.
Categories
- Community (2,386)
- Covid (993)
- CTO Events (6)
- News (3,024)
- Pilots (21)